310 related articles for article (PubMed ID: 8822629)
1. NK recognition of cytomegalovirus-infected endothelial cells depends on viral replication and MHC class I expression.
Weinberg A; Zhang L; Tuder RM
Viral Immunol; 1996; 9(2):131-40. PubMed ID: 8822629
[TBL] [Abstract][Full Text] [Related]
2. Alloreactive cytotoxic CD4+ responses elicited by cytomegalovirus-infected endothelial cells: role of MHC class I antigens.
Weinberg A; Zhang L; Hayward AR
Viral Immunol; 2000; 13(1):37-47. PubMed ID: 10733167
[TBL] [Abstract][Full Text] [Related]
3. Natural killer cell lysis of cytomegalovirus (CMV)-infected cells correlates with virally induced changes in cell surface lymphocyte function-associated antigen-3 (LFA-3) expression and not with the CMV-induced down-regulation of cell surface class I HLA.
Fletcher JM; Prentice HG; Grundy JE
J Immunol; 1998 Sep; 161(5):2365-74. PubMed ID: 9725232
[TBL] [Abstract][Full Text] [Related]
4. Lysis of pig endothelium by IL-2 activated human natural killer cells is inhibited by swine and human major histocompatibility complex (MHC) class I gene products.
Itescu S; Artrip JH; Kwiatkowski PA; Wang SF; Minanov OP; Morgenthau AS; Michler RE
Ann Transplant; 1997; 2(1):14-20. PubMed ID: 9869836
[TBL] [Abstract][Full Text] [Related]
5. Cytomegalovirus (CMV)-specific lysis of CMV-infected target cells can be mediated by both NK-like and virus-specific cytotoxic T lymphocytes.
Gehrz RC; Rutzick SR
Clin Exp Immunol; 1985 Jul; 61(1):80-9. PubMed ID: 2994924
[TBL] [Abstract][Full Text] [Related]
6. Human fibroblasts transfected with cytomegalovirus immediate-early genes show increased MHC class I expression and are targets for natural killer cell-mediated cytotoxicity.
Nyquist AC; Zhang L; Weinberg A
Viral Immunol; 2002; 15(1):147-54. PubMed ID: 11952136
[TBL] [Abstract][Full Text] [Related]
7. Modulation of natural killer cell cytotoxicity in human cytomegalovirus infection: the role of endogenous class I major histocompatibility complex and a viral class I homolog.
Leong CC; Chapman TL; Bjorkman PJ; Formankova D; Mocarski ES; Phillips JH; Lanier LL
J Exp Med; 1998 May; 187(10):1681-7. PubMed ID: 9584146
[TBL] [Abstract][Full Text] [Related]
8. Antiviral activity against CMV-infected fibroblasts in pediatric patients transplanted with CD34(+)-selected allografts from alternative donors.
Lang P; Griesinger A; Hamprecht K; Feuchtinger T; Schumm M; Neuhäuser F; Greil J; Martin D; Handgretinger R; Niethammer D
Hum Immunol; 2004 May; 65(5):423-31. PubMed ID: 15172441
[TBL] [Abstract][Full Text] [Related]
9. HLA-E-restricted recognition of human cytomegalovirus by a subset of cytolytic T lymphocytes.
Romagnani C; Pietra G; Falco M; Mazzarino P; Moretta L; Mingari MC
Hum Immunol; 2004 May; 65(5):437-45. PubMed ID: 15172443
[TBL] [Abstract][Full Text] [Related]
10. IFN-α augments natural killer-mediated antibody-dependent cellular cytotoxicity of HIV-1-infected autologous CD4+ T cells regardless of major histocompatibility complex class 1 downregulation.
Tomescu C; Tebas P; Montaner LJ
AIDS; 2017 Mar; 31(5):613-622. PubMed ID: 28225449
[TBL] [Abstract][Full Text] [Related]
11. The role of MHC class I expression in rat NK cell-mediated lysis of syngeneic tumor cells and virus-infected cells.
Giezeman-Smits KM; Kuppen PJ; Ensink NG; Eggermont AM; Stals F; Wonigeit K; Fleuren GJ
Immunobiology; 1996 Aug; 195(3):286-99. PubMed ID: 8877403
[TBL] [Abstract][Full Text] [Related]
12. Hcmv-miR-UL112 attenuates NK cell activity by inhibition type I interferon secretion.
Huang Y; Chen D; He J; Cai J; Shen K; Liu X; Yang X; Xu L
Immunol Lett; 2015 Feb; 163(2):151-6. PubMed ID: 25530545
[TBL] [Abstract][Full Text] [Related]
13. Expression of killer cell immunoglobulin-like receptors (KIRs) by natural killer cells during acute CMV infection after kidney transplantation.
de Rham C; Hadaya K; Bandelier C; Ferrari-Lacraz S; Villard J
Transpl Immunol; 2014 Sep; 31(3):157-64. PubMed ID: 25158213
[TBL] [Abstract][Full Text] [Related]
14. Rat interleukin-2-activated natural killer (A-NK) cell-mediated lysis is determined by the presence of CD18 on A-NK cells and the absence of major histocompatibility complex class I on target cells.
Smits KM; Kuppen PJ; Eggermont AM; Tamatani T; Miyasaka M; Fleuren GJ
Eur J Immunol; 1994 Jan; 24(1):171-5. PubMed ID: 7912675
[TBL] [Abstract][Full Text] [Related]
15. Cytokines alter target cell susceptibility to lysis: I. Evaluation of non-major histocompatibility complex-restricted effectors reveals differential effects on natural and lymphokine-activated killing.
Wiebke EA; Custer MC; Rosenberg SA; Lotze MT
J Biol Response Mod; 1990 Apr; 9(2):113-26. PubMed ID: 2111373
[TBL] [Abstract][Full Text] [Related]
16. Cytomegalovirus infection amplifies class I major histocompatibility complex expression on cultured human endothelial cells.
Tuder RM; Weinberg A; Panajotopoulos N; Kalil J
J Heart Lung Transplant; 1994; 13(1 Pt 1):129-38. PubMed ID: 8167118
[TBL] [Abstract][Full Text] [Related]
17. Renal allograft rejection: protection of renal epithelium from natural killer cells by cytokine-induced up-regulation of class I major histocompatibility antigens.
Lin Y; Proud G; Taylor RM; Kirby JA
Immunology; 1993 Jun; 79(2):290-7. PubMed ID: 8344707
[TBL] [Abstract][Full Text] [Related]
18. Human cytomegalovirus UL18 alleviated human NK-mediated swine endothelial cell lysis.
Kim JS; Choi SE; Yun IH; Kim JY; Ahn C; Kim SJ; Ha J; Hwang ES; Cha CY; Miyagawa S; Park CG
Biochem Biophys Res Commun; 2004 Feb; 315(1):144-50. PubMed ID: 15013438
[TBL] [Abstract][Full Text] [Related]
19. Induction of swine major histocompatibility complex class I molecules on porcine endothelium by tumor necrosis factor-alpha reduces lysis by human natural killer cells.
Kwiatkowski P; Artrip JH; John R; Edwards NM; Wang SF; Michler RE; Itescu S
Transplantation; 1999 Jan; 67(2):211-8. PubMed ID: 10075583
[TBL] [Abstract][Full Text] [Related]
20. Lysis of human arterial smooth muscle cells infected with herpesviridae by peripheral blood mononuclear cells: implications for atherosclerosis.
Datta SK; Tumilowicz JJ; Trentin JJ
Viral Immunol; 1993; 6(2):153-60. PubMed ID: 8216714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
